Natural Foci and Long-Term Analysis of the Leptospirosis Incidence in the Russian Federation, Forecast for 2025

The aim is the forecast of the leptospirosis epidemic manifestations for 2025 in the Russian Federation based on an analysis of the long-term incidence and the epizootiological monitoring data from 2024. Leptospirosis foci are a worldwide public health problem. In the Russian Federation, the average annual incidence of leptospirosis for 2000–2024 (excluding 2020–2021) is 0.39±0.084 per 100 thousand population, mainly sporadic cases are registered, mortality remains high and varies from 2.1 to 8.4 %. In 2024, human leptospirosis was established in all federal districts with maximum incidence levels in the North-Western and Southern federal Districts. Infection with pathogenic Leptospira in small mammals and water was detected in 60 subjects of the Russian Federation in all federal districts. The main volume of the population specific prevention falls on the Southern Federal District and accounts 85.5 % from 15,156 vaccinated. Human disease risks persist in areas with active leptospirosis natural foci, especially in the Central, Far Eastern and North-Western Federal Districts. Imported cases of infection are possible both from highly endemic countries and between the territories of the Russian Federation.

1. Anan’ina Yu.V. [Leptospira – causative agents of human leptospirosis]. In: Labinskaya A.S., Kostyukova N.N., Ivanova S.M., editors. [A Guide to Medical Microbiology. Special Medical Microbiology and Etiological Diagnostics of Infections]. Book II. Moscow: “BINOM Publishing House”; 2022. P. 821–43.

2. Bradley E.A., Lockaby G. Leptospirosis and the environment: A review and future directions. Pathogens. 2023; 12(9):1167. DOI: 10.3390/pathogens12091167.

3. Petakh P., Behzadi P., Oksenych V., Kamyshnyi O. Current treatment options for leptospirosis: a mini-review. Front. Microbiol]. 2024; 15:1403765. DOI: 10.3389/fmicb.2024.1403765.

4. Leptospirosis. Annual Epidemiological Report for 2022. ECDC; 2024. [Internet]. Available from: https://www.ecdc.europa.eu/en/publications-data/leptospirosis-annual-epidemiologicalreport-2022.

5. Zorilla R., Ching L.L., Elisara T., Kramer K., Nerurkar V.R. Re-emerging, under-recognized zoonotic, and neglected tropical diseases in Hawai’i. Jpn. J. Infect. Dis. 2024; 77(4):187–200. DOI: 10.7883/yoken.JJID.2023.476.

6. Leptospirosis. CDC; 2025. [Internet]. Available from: https://www.cdc.gov/leptospirosis/about/index.html.

7. Haggerty N. Cluster of farmworkers diagnosed with rare animal-borne disease in Ventura County. Los Angeles Times. Climate & Environment. Nov. 22, 2024. [Internet]. Available from: https://www. latimes.com/environment/story/2024-11-22/ventura-farmworkersdiagnosed-with-rare-animal-borne-disease.

8. Schneider M.C., Leonel D.G., Hamrick P.N., de Caldas E.P., Velásquez R.T., Mendigaña Paez F.A., González Arrebato J.C., Gerger A., Maria Pereira M., Aldighieri S. Leptospirosis in Latin America: exploring the first set of regional data. Rev. Panam. Salud Publica. 2017; 41:e81. DOI: 10.26633/RPSP.2017.81.

9. Browne E.S., Pereira M., Barreto A., Zeppelini C.G., de Oliveira D., Costa F. Prevalence of human leptospirosis in the Americas: a systematic review and meta-analysis. Rev. Panam. Salud Publica. 2023; 47:e126. DOI: 10.26633/RPSP.2023.126.

10. Australian Government Department of Health and Aged Care, National Notifiable Disease Surveillance System. National Communicable Disease Surveillance Dashboard. Canberra: Australian Government Department of Health and Aged Care; 2025. [Internet]. Available from: https://nindss.health.gov.au/pbi-dashboard/.

11. Brown D.R., Peiris R., Waller C., Stedman E.M., Fitzpatrick S.E., Krause V.L., Draper A.D. An outbreak of leptospirosis associated with cattle workers during the wet season in the Northern Territory of Australia, 2021. Commun. Dis. Intell. (2018). 2022; 46. DOI: 10.33321/cdi.2022.46.23.

12. Ferson M.J., Flanigan S., Westman M.E., Pastrana Velez A.M., Knobel B., Cains T., Martinello M. Rare urban-acquired human leptospirosis and environmental health investigation in Sydney, Australia. Commun. Dis. Intell. (2018). 2025; 49. DOI: 10.33321/cdi.2025.49.011.

13. Kakita T., Okano S., Kyan H., Miyahira M., Taira K., Kitashoji E., Koizumi N. Laboratory diagnostic, epidemiological, and clinical characteristics of human leptospirosis in Okinawa Prefecture, Japan, 2003–2020. PLoS Negl. Trop. Dis. 2021; 15(12):e0009993. DOI: 10.1371/journal.pntd.0009993.

14. Suzuki R., Terayama M., Tanda M. Severe leptospirosis infection in a non-epidemic area. IDCases. 2021; 26:e01345. DOI: 10.1016/j.idcr.2021.e01345.

15. Mutoh Y., Koizumi N., Morino E., Hayakawa K., Kato Y., Ohmagari N. Leptospirosis cases in the Tokyo metropolitan area, Japan. Jpn. J. Infect. Dis. 2017; 70(6):669–71. DOI: 10.7883/yoken. JJID.2017.108.

16. Beware of Rat Fever. Daily News. 2025. [Internet]. Available from: https://www.dailynews.lk/2025/05/19/featured/780142/beware-of-rat-fever-2/.

17. Lisovsky A.A., Sheftel B.I., Savelyev A.P., Ermakov O.A., Kozlov Yu.A., Smirnov D.G., Stakheev V.V., Glazov D.M. [Mammals of Russia: List of Species and Applied Aspects. Proceedings of the Zoological Museum of Moscow State University]. Vol. 56. Moscow: “Association of Scientific Publications of the CMC”; 2019. 191 p.

18. Zaks L. [Statistical Estimation]. Moscow: “Statistica”; 1976. 600 p.

19. Savilov E.D., Astaf’ev V.A., Zhdanov S.N., Zarudnev E.A. [Epidemiological Analysis: Methods of Statistical Processing of the Material]. Novosibirsk: “Science Center”; 2011. 156 p.

20. Trankvilevsky D.V., Skudareva O.N., Igonina E.P., Kiseleva E.Yu., Korzun V.M., Verzhutskaya Yu.A., Noskov A.K., Kulikalova E.S., Breneva N.V., Budaeva S.E., Morozova I.V., Trishina A.V. [Analysis of the epizootic and epidemiological situation on leptospirosis in 2023 and forecast for 2024 in the Russian Federation]. Problemy Osobo Opasnykh Infektsii Problemy Osobo Opasnykh Infektsii [Problems of Particularly Dangerous Infections]. 2024; (3):51–62. DOI: 10.21055/0370-1069-2024-3-51-62.